Tanjina Akter
- Pathology and Forensic Medicine top 10%
- Systemic Sclerosis and Related Diseases 10
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 12
- Pulmonary Hypertension Research and Treatments 2
-
- Liver physiology and pathology 2
-
- Mast cells and histamine 3
-
- Eosinophilic Disorders and Syndromes 2
-
- Polyomavirus and related diseases 2
-
- Chemical Synthesis and Analysis 1
- Co-authors
- Galina S. BogatkevichRichard M. SilverPaul J. NietertJoanne van RynIlia AtanelishviliKristin B. HighlandJulio CharlesRobert M. Elashoff
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (2 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Tanjina Akter
20 papers receiving 339 citations
Peers
Comparison fields: 5 of 54
- Pathology and Forensic Medicine 138
- Pulmonary and Respiratory Medicine 193
- Internal Medicine 19
- Dermatology 22
- Hepatology 17
Countries citing papers authored by Tanjina Akter
This map shows the geographic impact of Tanjina Akter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanjina Akter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanjina Akter more than expected).
Fields of papers citing papers by Tanjina Akter
This network shows the impact of papers produced by Tanjina Akter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanjina Akter. The network helps show where Tanjina Akter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tanjina Akter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 7 | |
| 8 | 2019 | 61 | |
| 9 | 2019 | 13 | |
| 10 | Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease. | 2019 | 11 |
| 11 | 2018 | 1 | |
| 12 | 2018 | 1 | |
| 13 | 2017 | 5 | |
| 14 | 2016 | 2 | |
| 15 | 2015 | 8 | |
| 16 | 2014 | 41 | |
| 17 | 2013 | 39 | |
| 18 | 2013 | 15 | |
| 19 | 2011 | 89 | |
| 20 | 2011 | 18 |
About Tanjina Akter
Tanjina Akter is a scholar working on Drug Discovery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 344 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Systemic Sclerosis and Related Diseases (10 papers), Mast cells and histamine (3 papers), Liver physiology and pathology (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Polyomavirus and related diseases (2 papers), Pulmonary Hypertension Research and Treatments (2 papers) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (138 citations), Pulmonary and Respiratory Medicine (193 citations) and Internal Medicine (19 citations). Tanjina Akter has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Galina S. Bogatkevich, Richard M. Silver, Paul J. Nietert, Joanne van Ryn, Ilia Atanelishvili, Kristin B. Highland, Julio Charles, Robert M. Elashoff, Philip J. Clements and Masataka Kuwana. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.